Effects of Nabilone on Sleep Outcomes in Patients with Parkinson's Disease: A Post‐hoc Analysis of NMS‐Nab Study
Movement Disorders Clinical Practice2022Vol. 9(6), pp. 751–758
Citations Over TimeTop 10% of 2022 papers
Marina Peball, Klaus Seppi, Florian Krismer, Hans‐Günther Knaus, Sabine Spielberger, Beatrice Heim, Philipp Ellmerer, Mario Werkmann, Werner Poewe, Atbin Djamshidian
Abstract
This post-hoc analysis of the NMS-Nab trial suggests that nabilone has beneficial effects on sleep outcomes in PD patients experiencing sleep problems at baseline.The original trial was registered with ClinicalTrials.gov (NCT03769896, https://clinicaltrials.gov/ct2/show/NCT03769896) and EudraCT (2017-000192-86).
Related Papers
- → A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia(2002)434 cited
- → Altered Placebo and Drug Labeling Changes the Outcome of Episodic Migraine Attacks(2014)391 cited
- → Gender Differences in Placebo Analgesia: Event-Related Potentials and Emotional Modulation(2011)116 cited
- → Conditioned Placebo Analgesia Persists When Subjects Know They Are Receiving a Placebo(2015)116 cited
- → Μελέτη της πολυπαραγοντικής αναλγησίας στο μετεγχειρητικό πόνο μετά από λαπαροσκοπική χολοκυστεκτομή(2014)